Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

Digestive and Liver Disease

Volumn 34, Issue 3, 2002, Pages 204-211

  Lonardo, A ^c   Loria, P ^b   Leonardi, F ^b   Borsatti, A ^b   Neri, P ^a   Pulvirenti, M ^a   Verrone, A M ^b   Bagni, A ^b   Bertolotti, M ^b   Ganazzi, D ^b   Carulli, N ^b  

^a City Hospital   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Insulin resistance; Iron metabolism; Metabolic syndrome; Non alcoholic fatty liver disease; Quantitative insulin sensitivity check index

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; INSULIN; IRON; TRANSFERRIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GENDER; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON METABOLISM; IRON STORAGE; LIVER BIOPSY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; RISK ASSESSMENT;

EID: 18344386388     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80194-3     Document Type: Article

References (68)

1. Nonalcoholic steatohepatitis
2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathologic severity
3. Prevalence of and risk factors for hepatic steatosis in Northern Italy
4. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients
5. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients
6. Pathological and virological findings in patients with persistent hypertransaminasemia of unknown aetiology
7. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
8. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
9. Hepatic steatosis in chronic hepatitis C virus infection: Prevalence and clinical correlation
10. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM
11. Physical activity, metabolic factors, and the incidence of coronary heart disease and type 2 diabetes
12. Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study
13. Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease
14. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
15. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case-control study
16. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis
17. Fatty liver and nonalcoholic steatohepatitis: Where do we stand and where are we going?
18. Nonalcoholic steatohepatitis and hepatocellular carcinoma: Natural history?
19. Hepatocellular carcinoma arising in non-alcoholic steatohepatitis
20. Hepatic steatosis as a potential risk factor for major hepatic resection
21. An approach to the rational use of steatotic donor livers in liver transplantation
22. Fatty liver in transplantation and surgery
23. Association of nonalcoholic fatty liver disease with insulin resistance
24. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondria abnormalities
25. Insulin resistance and mitochondrial abnormalities in NASH: A cool look into a burning issue
26. Etiopathogenesis of nonalcoholic steatohepatitis
27. Insulin resistance in non-alcoholic steatohepatitis
28. Insulin resistance in nonalcoholic fatty liver disease. A clinical perspective
29. Consensus development conference on insulin resistance
30. The cardiovascular dysmetabolic syndrome
31. Non-alcoholic steatohepatitis and iron: Increased prevalence of the HFE gene in non-alcoholic steatohepatitis
32. Insulin-resistance associated hepatic iron overload
33. Diabetes and serum ferritin concentration among U.S. adults
34. Serum ferritin as a component of the insulin resistance syndrome
35. Insulin resistance influences iron metabolism and hepatic steatosis in type II diabetes
36. Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution
37. The bright liver syndrome. Prevalence and determinants of a "bright" liver echopattern
38. Epidemiology of gallstone disease in Italy: Prevalence data of the multicenter Italian Study on Cholelithiasis (M.I.COL.)
39. Estimation of the low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge
40. Meeting report: International Autoimmune Hepatitis Group
41. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans
42. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
43. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions
44. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors
45. The natural history of nonalcoholic fatty liver: A follow-up study
46. Nonalcoholic steatohepatitis. Clinicopathological comparison with alcoholic hepatitis in ambulatory and hospitalized patients
47. Liver pathology and the metabolic syndrome X in severe obesity
48. Fatty infiltration of liver in hyperlipidemic patients
49. Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight
50. Fatty liver - An additional and treatable feature of the insulin resistance syndrome
51. Nonalcoholic fatty liver disease. A feature of the metabolic syndrome
52. Non-alcoholic fatty liver: Another feature of the metabolic syndrome?
53. Hyperinsulinema and insulin resistance in nonalcoholic steatohepatitis
54. More clues to the relationship between hepatic iron and steatosis: An association with insulin resistance?
55. Insulin resistance. The metabolic syndrome X
56. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
57. Renal effects of insulin in man
58. Extrarticular diseases and findings in gout
59. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men
60. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: A pilot study
61. High-protein diets in hyperlipidemia: Effect of wheat gluten on serum lipids, uric acid, and renal function
62. Moderate consumption of beer, red wine and spirits has counteracting effects on plasma antioxidants in middle-aged men
63. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus
64. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992
65. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers
66. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study
67. Metformin reverses fatty liver disease in obese, leptin-deficient mice
68. A pilot study of a thiazolinedione, troglitazone, in nonalcoholic steatohepatitis